License to Cure for BioPharma

Accelerate therapeutic development, approval, manufacturing, and supply, in a global landscape

Pharmaceutical and Biotechnology companies are challenged with the ability to deliver operational excellence with full traceability and to efficiently manage the ever changing global regulatory environment. License to Cure for BioPharma is an Industry Solution Experience that uniquely provides the ability to accelerate therapeutic development, approval, manufacturing, and supply, in a global landscape by leveraging an extensive, connected and comprehensive regulatory and quality platform.

License to Cure for BioPharma provides digital continuity for organizations to manage the complexity of an ever increasing number of medicinal products with a single version of the truth based on IDMP standards and enables change impact analysis, informed decision making and full IP reuse to deliver quality best practices shifting the paradigm of regulatory as a constraint to regulatory as an asset.

Download the Solution Flyer

The Key to Bio-Pharma Transformation by Axendia

Pharma and biotech organizations need game-changing ideas to survive as they look for ways to accelerate innovation and improve efficiency. One area ready for transformational change is the product lifecycle management process (PLM).

Axendia’s latest white paper: “The Key to Bio-Pharma Transformation” will explore how Pharmaceuitcal and Biotech companies can benefit by adopting a more holistic approach to PLM to accelerate innovation cycles and innovate through digital continuity.

Download

Benefits of License to Cure for BioPharma

Reduce time to market and cost of market expansion in BioPharma

Transition from a traditional product oriented model to the delivery of therapeutic solutions using a system that enables companies to be more reactive to quickly meet today's market needs.
Leverage Regulatory Intelligence to Drive Your Global Strategy in BioPharma

Spend less time, reduce the risk of non-compliance, improve traceability and accelerate global expansion
Enhance Decision-Making in BioPharma

Enhance decision-making through real-time views across the lifecycle of innovation
Ensure a consistent approach to quality, compliance, and regulatory activities for BioPharma

The 3DEXPERIENCE® platform enables businesses to transition from historical and outdated practices to a connected and transformative environment across your extended ecosystem.

Adopt the Power of License to Cure for BioPharma

License to Cure for BioPharma provides digital continuity for organizations to manage the complexity of an ever increasing number of medicinal products with a single version of the truth.

Contact Sales Get a Quote

Success story

How Digital Transformation Drives Change and Collaboration in the Lab

Learn how Biogen addressed a challenge that is common with many pharma and biopharmaceutical companies: how to reduce inefficiency and improve the delivery of crucial documentation.

Read the full customer story

Life Sciences Industry > Collaboration in the Lab > Dassault Systèmes®

Included in License to Cure for BioPharma

Accelerate therapeutic approval, production, and patient adoption in a global landscape

Collaborative Planning, Execution & Analytics

Coordinate scope, schedule and resources to deliver the project on-time and within business constraints; and reveal and manage risks based on real-time information.

Discover

Product Specification & Enterprise Release

Standardize the way specification data is captured and stored for use across organizations

Discover

Quality Document Management

Efficient, compliant management of controlled documents across the enterprise including functions such as Quality Assurance, Manufacturing, R&D, and Regulatory Affairs

Discover

Audit Scheduling & Execution

Provide a comprehensive cross industry quality management solution that embeds quality and compliance directly into the product development process

Discover

Quality Incident & CAPA Management

Integrate the Quality Management Systems operations across the global enterprise, fostering compliance with GxP

Discover

Regulatory Tracking & Management

Pharmaceutical and Biotech companies can control regulatory affairs and operations globally, fostering compliance and improving regulatory submission efficiency

Discover

Collaborative Planning, Execution & Analytics

Coordinate scope, schedule and resources to deliver the project on-time and within business constraints; and reveal and manage risks based on real-time information.

Discover

Product Specification & Enterprise Release

Standardize the way specification data is captured and stored for use across organizations

Discover

Quality Document Management

Efficient, compliant management of controlled documents across the enterprise including functions such as Quality Assurance, Manufacturing, R&D, and Regulatory Affairs

Discover

Audit Scheduling & Execution

Provide a comprehensive cross industry quality management solution that embeds quality and compliance directly into the product development process

Discover

Quality Incident & CAPA Management

Integrate the Quality Management Systems operations across the global enterprise, fostering compliance with GxP

Discover

Regulatory Tracking & Management

Pharmaceutical and Biotech companies can control regulatory affairs and operations globally, fostering compliance and improving regulatory submission efficiency

Discover

Discover also